BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 24685381)

  • 1. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
    Jaksch P; Taghavi S; Klepetko W; Salama M
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome.
    Kastelijn EA; van Moorsel CH; Ruven HJ; Korthagen NM; Kwakkel-van Erp JM; van de Graaf EA; Zanen P; van Kessel DA; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2013 Mar; 30(1):28-35. PubMed ID: 24003532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic bronchiolitis obliterans syndrome risk monitoring in lung transplant recipients.
    Wolf T; Oumeraci T; Gottlieb J; Pich A; Brors B; Eils R; Haverich A; Schlegelberger B; Welte T; Zapatka M; von Neuhoff N
    Transplantation; 2011 Aug; 92(4):477-85. PubMed ID: 21716170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.
    D'Ovidio F; Mura M; Tsang M; Waddell TK; Hutcheon MA; Singer LG; Hadjiliadis D; Chaparro C; Gutierrez C; Pierre A; Darling G; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1144-52. PubMed ID: 15867792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1 is a useful biomarker for early detection of bronchiolitis obliterans in lung transplant recipients.
    Salama M; Jaksch P; Andrukhova O; Taghavi S; Klepetko W; Aharinejad S
    J Thorac Cardiovasc Surg; 2010 Dec; 140(6):1422-7. PubMed ID: 21078427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset.
    Meloni F; Salvini R; Bardoni AM; Passadore I; Solari N; Vitulo P; Oggionni T; Viganò M; Pozzi E; Fietta AM
    J Heart Lung Transplant; 2007 Nov; 26(11):1135-43. PubMed ID: 18022079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
    Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
    Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
    Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation.
    Ohshimo S; Bonella F; Sommerwerck U; Teschler H; Kamler M; Jakob HG; Kohno N; Guzman J; Costabel U
    J Heart Lung Transplant; 2011 Dec; 30(12):1374-80. PubMed ID: 21871820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
    Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
    Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
    Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metalloproteinase Profiling in Lung Transplant Recipients With Good Outcome and Bronchiolitis Obliterans Syndrome.
    Heijink IH; Rozeveld D; van der Heide S; van der Bij W; Bischoff R; van Oosterhout AJ; van der Toorn M
    Transplantation; 2015 Sep; 99(9):1946-52. PubMed ID: 25651312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis.
    Furuhashi K; Suda T; Nakamura Y; Inui N; Hashimoto D; Miwa S; Hayakawa H; Kusagaya H; Nakano Y; Nakamura H; Chida K
    Respir Med; 2010 Aug; 104(8):1204-10. PubMed ID: 20347285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
    Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI
    J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration.
    Reynaud-Gaubert M; Marin V; Thirion X; Farnarier C; Thomas P; Badier M; Bongrand P; Giudicelli R; Fuentes P
    J Heart Lung Transplant; 2002 Jul; 21(7):721-30. PubMed ID: 12100898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?
    Vos R; Vanaudenaerde BM; Geudens N; Dupont LJ; Van Raemdonck DE; Verleden GM
    Eur Respir J; 2008 May; 31(5):1037-45. PubMed ID: 18256072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.